Quadrature Capital’s Sight Sciences SGHT Stock Holding History

Quadrature Capital’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,387	Closed	-$35.7K	–	1612
2025 Q3	$35.7K	Buy	+10,387	New	+$38.7K	﹤0.01%	973

Other funds holding SGHT

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Quadrature Capital's SGHT Position: Q4 2025 in Review

Quadrature Capital sold out of Sight Sciences (SGHT) in Q4 2025, closing a stake of 10,387 shares — an estimated $35.7K sold.

Quadrature Capital first reported a position in SGHT in Q3 2025 and held it in 1 quarter. The position peaked at $35.7K in Q3 2025. 111 funds tracked by Wall St. Rank hold SGHT as of Q4 2025.

Quadrature Capital reported no remaining Sight Sciences position as of Q4 2025 after selling out during the quarter.
Quadrature Capital sold 10,387 Sight Sciences shares in Q4 2025, an estimated $35.7K.
Quadrature Capital first reported a position in Sight Sciences in Q3 2025 and held it in 1 quarter.
Quadrature Capital's Sight Sciences position peaked at $35.7K in Q3 2025.
111 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2025.

Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.